Skip to main content

Table 1 Associations between race and outcomes of presenting with advanced disease, and use of definitive therapy

From: Racial disparities in conditional survival of patients with bladder cancer: a population-based study

Races

Advanced disease at diagnosis†

 

Definitive therapy‡

 

OR§

95% CI

P-value

 

OR¶

95% CI

P-value

White

Ref.

   

Ref.

  

African American

1.64

1.46–1.83

< 0.001

 

0.80

0.71–0.91

0.001

API

1.05

0.90–1.23

0.541

 

0.95

0.82–1.11

0.543

  1. Abbreviations: API, Asian/Pacific Islander; CI, confidence interval; OR, odds ratio
  2. †This study defined inoperable locally advanced (T4b and any N; or any T and N2–3) or metastatic (M1) bladder cancer as advanced disease
  3. ‡Excluded patients with advanced disease
  4. §OR adjusted for demographic variables (sex, age, year of diagnosis, marital status, insurance status, geographic region, residence type, education, and median household income)
  5. ¶OR adjusted for demographic variables and tumor-related factors (tumor grade, tumor stage, and nodal stage)
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us